AAAS and Science Translational Medicine invite applications for the 2015 AAAS Martin and Rose Wachtel Cancer Research Award. This annual award, funded by an endowment established through a generous bequest from Martin L. Wachtel, honors early-career investigators who have performed outstanding work in the field of cancer research. Entrants must have received their Ph.D. or M.D. within the last 10 years. The award winner(s) are invited to deliver a public lecture on their research and receive an unrestricted cash award of $25,000. The award winning Essay(s) will be published as a Focus article in Science Translational Medicine.
The deadline for application has been extended to 15 March 2015.
Entry packages must include the following materials, written in English:
Send all materials in the entry package in pdf format to Yevgeniya Nusinovich, cancer editor at Science Translational Medicine, at email@example.com , with Wachtel Award Entry in the subject line. Please note: If your contact information changes after submission then you must inform us at firstname.lastname@example.org .
The editors of Science Translational Medicine will be responsible for the initial evaluation of the Essays. Approximately the top 10 percent of the Essays will be forwarded to the judging panel. The judging panel is composed of prominent international researchers in the field of cancer. The applicants will be rated on two characteristics: scientific quality and significance of their research, and the clarity and style of the Essay.
The winners of the 2014 AAAS Martin and Rose Wachtel Cancer Research Award were Li Ma, an Assistant Professor at the University of Texas MD Anderson Cancer Center, and Jeffrey Tyner, an Assistant Professor at Oregon Health & Science University.
The winner of the inaugural AAAS Martin and Rose Wachtel Cancer Research Award in 2013 was Scott A. Tomlins, an Assistant Professor in the Michigan Center for Translational Pathology at the University of Michigan Medical School.
The 3 runners up were: Gregory Beatty, University of Pennsylvania School of Medicine; Michele De Palma, Swiss Federal Institute of Technology Lausanne; and Franziska Michor, Dana Farber Cancer Institute.